HCA Healthcare holds the cleaner structural position, with the lead spread across profitability and stability. Hikma Pharmaceuticals does not offset that deficit through any equally strong structural edge elsewhere. On the market side, HCA Healthcare is in better shape — its trend is intact while Hikma Pharmaceuticals's trend has broken down. That puts structure and market broadly in agreement — HCA Healthcare's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels.
This is not just a one-metric split: both profitability and stability materially support the lead. The overall score gap is 17 points in favour of HCA Healthcare, Inc..
This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.
The pair sits on a clearly comparable long-term path, though it is not a near-twin match.
The clearest structural overlap shows up in margin consistency and revenue stability.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
HCA Healthcare, Inc. is stronger, but the price setup still looks more supportive for Hikma Pharmaceuticals PLC.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 10.2-point ROIC advantage.
Hikma Pharmaceuticals PLC still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
The lead is built on both profitability and stability, making it broader than a single-dimension result.
Break down the HCA vs HIK.L comparison across all dimensions with the full interactive tool.
Explore how HCA and HIK.L each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.